Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sun Pharmaceutical Industries has announced that FDA has granted an approval for the abbreviated new drug application to market generic Paraplatin, carboplatin injection.
Subscribe to our email newsletter
These generic versions of carboplatin 10mg/ml injections packed in 5ml, 15ml and 45ml single use vials are bioequivalent to Paraplatin injections distributed by Bristol Myers Squibb Oncology/Virology.
Carboplatin injections are indicated as initial and secondary therapy in patients with advanced ovarian carcinoma.